FMC vs MAZE · rev $1.22B vs $525.3M cap
FMC Corporation (FMC) versus Maze Therapeutics, Inc. Common Stock (MAZE) — a side-by-side from cached financials, not a winner call.
FMC Corporation (FMC) is a agricultural inputs company listed on NYSE.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Latest reported FMC revenue for 2024-12-31 was $1.22B. Net income was -$16.1M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. FMC currently screens at market cap $1.50B.
Latest reported MAZE revenue for 2025-06-30 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-09-30 to 2025-06-30. MAZE currently screens at market cap $525.3M.
FMC currently screens at market cap $1.50B. MAZE currently screens at market cap $525.3M.
Not investment advice. Open the FMC and MAZE stock pages for the full models.
Not investment advice.